Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer indicates an updated ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3. This reflects a platform/version change rather than a change to the study record details.
    Difference
    0.1%
    Check dated 2026-04-25T06:20:55.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:53:08.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    The Record History now includes a new version entry (v3.5.0) and removes the earlier version (v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-20T04:00:00.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T21:33:04.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and the funding notice banner and the previous revision (v3.4.1) were removed.
    Difference
    0.7%
    Check dated 2026-02-12T02:06:16.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Additions include a general site status notice about government funding and the current revision tag (v3.4.1). Deletion removes the previous revision tag (v3.4.0).
    Difference
    0.7%
    Check dated 2026-02-04T12:34:41.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.